CMP-001
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for CMP-001, covering 2021-09-16 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma [Phase 2]